Literature DB >> 8929422

Local opioid withdrawal in rat single periaqueductal gray neurons in vitro.

B Chieng1, M D Christie.   

Abstract

Opioid dependence in ventrolateral periaqueductal gray (PAG) neurons was studied by using intracellular recordings from brain slices. In slices from morphine-dependent rats maintained in morphine (5 microM) in vitro, action potential frequencies of opioid-sensitive neurons did not differ from untreated control neurons but were greater than in control neurons maintained in morphine in vitro, indicating development of tolerance. Naloxone (100 nM or 1 microM) depolarized 25 of 51 neurons from morphine-dependent rats maintained in morphine in vitro, 19 of which previously had been classified as opioid-sensitive. Action potential frequencies in the presence of naloxone were greater than in control neurons in the absence of opioids, as well as in control neurons in the presence of both morphine and naloxone, demonstrating opioid withdrawal. In slices from control animals, opioid-induced hyperpolarizations and naloxone-induced depolarizations (in the presence of morphine) reversed polarity near expected EK (-111 +/- 3 mV and -113 +/- 3 mV, respectively). In contrast, the reversal potential of naloxone-induced depolarizations was more negative than expected in neurons from dependent animals (-143 +/- 9 mV), indicating that the depolarization was not attributable simply to antagonism of a K-conductance increase. Naloxone-induced depolarizations were not inhibited by tetrodotoxin (1 microM), bicuculline (30 microM), 6-cyano-7-nitroquinoxaline-2,3-dione (10 microM), or prazosin (300 nM), suggesting no involvement of major synaptic neurotransmitters. Clonidine (1 microM) and baclofen (30 microM) overcame naloxone-induced depolarizations. These results demonstrate development of both tolerance and withdrawal in PAG neurons and suggest induction of a novel opioid-sensitive current that could be involved in withdrawal behavior.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929422      PMCID: PMC6578948     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance.

Authors:  S K Sharma; W A Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  Effect of chronic morphine treatment on transmitter release from sympathetic varicosities of the mouse vas deferens.

Authors:  N A Lavidis
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.

Authors:  C Kennedy; G Henderson
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

4.  Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal.

Authors:  B Chieng; K A Keay; M J Christie
Journal:  Neurosci Lett       Date:  1995-01-02       Impact factor: 3.046

5.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

6.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

7.  Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro.

Authors:  P B Osborne; C W Vaughan; H I Wilson; M J Christie
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

8.  Hyperpolarization by GABAB receptor agonists in mid-brain periaqueductal gray neurones in vitro.

Authors:  B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain.

Authors:  J P Fry; A Herz; W Zieglgänsberger
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

10.  Characterization of acute homologous desensitization of mu-opioid receptor-induced currents in locus coeruleus neurones.

Authors:  P B Osborne; J T Williams
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more
  24 in total

1.  Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption.

Authors:  Carrie L Walters; Bao-Cheng Wang; Misty Godfrey; Duxin Sun; Colin D Funk; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 2.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

3.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors.

Authors:  Elena E Bagley; Jennifer Hacker; Vladimir I Chefer; Christophe Mallet; Gavan P McNally; Billy C H Chieng; Julie Perroud; Toni S Shippenberg; MacDonald J Christie
Journal:  Nat Neurosci       Date:  2011-10-30       Impact factor: 24.884

5.  Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.

Authors:  Adrianne R Wilson-Poe; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  J Physiol       Date:  2017-09-07       Impact factor: 5.182

6.  Regulators of G-Protein Signaling (RGS) Proteins Promote Receptor Coupling to G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels.

Authors:  Kylie B McPherson; Emily R Leff; Ming-Hua Li; Claire Meurice; Sherrica Tai; John R Traynor; Susan L Ingram
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

7.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

8.  Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway.

Authors:  S L Ingram; C W Vaughan; E E Bagley; M Connor; M J Christie
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice.

Authors:  Hans G Cruz; Frédérique Berton; Monica Sollini; Christophe Blanchet; Marco Pravetoni; Kevin Wickman; Christian Lüscher
Journal:  J Neurosci       Date:  2008-04-09       Impact factor: 6.167

10.  Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.

Authors:  Udita Datta; Leslie K Kelley; Jason W Middleton; Nicholas W Gilpin
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.